Invasive Meningococcal Disease caused by Neisseria meningitidis serogroup C

Also known as: Meningococcal Disease caused by Neisseria meningitidis serogroup C / Invasive Meningococcal Infection caused by Neisseria meningitidis serogroup C

DrugDrug NameDrug Description
DB10061Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccineA conjugate vaccine used to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
DB13890Meningococcal polysaccharide vaccine group CMeningococcal group C polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup C. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and...
DB15681Neisseria meningitidis group C capsular polysaccharide tetanus toxoid conjugate antigenNot Annotated
DB10799Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigenNeisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup c. The vaccine...
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount